CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Panbela Therapeutics Inc   (PBLA)
Other Ticker:  
 

Panbela Therapeutics Inc 's Leverage Ratio

PBLA's quarterly Leverage Ratio and Total Liabilities, Equity growth




PBLA Leverage Ratio (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter
Y / Y Equity Change -61.48 % - - - -13.23 %
Y / Y Total Liabilities Change 209.3 % 427.33 % 881.78 % 718.02 % 244.05 %
Leverage Ratio MRQ 5.5 - - - 0.68
Overall Ranking # 3234 # # # # 1901
Seq. Equity Change - - - - -35.56 %
Seq. Total Liabilities Change -0.62 % 6.7 % 15.37 % 152.83 % 69.44 %

New: More PBLA's historic Leverage Ratio results >>


Comment on PBLA Leverage Ratio in the first quarter 2023
In Spite of the repayements of liabilities of -0.62%, in I Quarter 2023 ,Leverage Ratio deteriorated to 5.5, above the company's average Leverage Ratio.

Within Major Pharmaceutical Preparations industry in the first quarter 2023, 395 other companies have achieved lower Leverage Ratio than Panbela Therapeutics Inc in the I Quarter 2023. While total ranking remained the same in the first quarter 2023 compared to the previous quarter at no. .

Explain Leverage Ratio?
Who are PBLA Customers?
What are PBLA´s Total Liabilities?
Leverage Ratio first quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 396
Healthcare Sector # 816
Overall Market # 3231


Leverage Ratio Statistics
High Average Low
13.1 2.51 0.1
(Jun 30 2018)   (Sep 30 2021)




Financial Statements
Panbela Therapeutics Inc 's Equity $ 3 Millions Visit PBLA's Balance sheet
Panbela Therapeutics Inc 's Total Liabilities $ 14 Millions Visit PBLA's Balance sheet
Source of PBLA's Sales Visit PBLA's Sales by Geography


Cumulative Panbela Therapeutics Inc 's Leverage Ratio

PBLA's Leverage Ratio for the trailling 12 Months

PBLA Leverage Ratio

 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter
Y / Y Equity TTM Growth -61.48 % - - - -13.23 %
Y / Y Total Liabilities TTM Growth 209.3 % 427.33 % 881.78 % 718.02 % 244.05 %
Leverage Ratio TTM - - 8.63 0.78 0.27
Total Ranking TTM # 1707 # 0 # 3620 # 1485 # 613
Seq. Equity TTM Growth - - - - -35.56 %
Seq. Total Liabilities TTM Growth -0.62 % 6.7 % 15.37 % 152.83 % 69.44 %

Leverage ratio ranking by company, industry and sector >> Back to PBLA Financial Strength Comparisons >> Compare PBLA Leverage Ratio to its Peers

TTM Leverage Ratio Comment
On the trailing twelve months basis Despite of the repayements of liabilities of -0.62% in the trailling twelve months ending in I Quarter 2023, Leverage Ratio decreased to -2.82, below Panbela Therapeutics Inc 's average Leverage Ratio.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry 395, during the past 12 months, other companies have achieved lower Leverage Ratio than Panbela Therapeutics Inc . While Leverage Ratio total ranking has deteriorated during the twelve months ending in the I Quarter 2023, compared to the prior period, from 0 to 1707.

Explain Leverage Ratio?
Who are PBLA Customers?
What are PBLA´s Total Liabilities?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 396
Healthcare Sector # 816
Within the Market # 3231


TTM Leverage Ratio Statistics
High Average Low
13.1 2.51 0.1
(Jun 30 2018)   (Sep 30 2021)




Companies with similar Leverage Ratio in the quarter ending Mar 31 2023, within Major Pharmaceutical Preparations Industry Leverage RatioMar 31 2023 MRQ Total LiabilitiesMar 31 2023 MRQ Equity
Journey Medical Corporation  11.79 $ 88.361  Millions$ 7.492  Millions
Fortress Biotech Inc   11.40 $ 225.755  Millions$ 19.806  Millions
Ocean Biomedical Inc   10.92 $ 16.865  Millions$ 1.544  Millions
Ocular Therapeutix Inc   10.03 $ 97.408  Millions$ 9.711  Millions
Xeris Biopharma Holdings Inc   9.69 $ 291.312  Millions$ 30.048  Millions
Harrow Health Inc   9.09 $ 195.615  Millions$ 21.528  Millions
Puma Biotechnology Inc   6.59 $ 170.410  Millions$ 25.847  Millions
Omeros Corporation  6.56 $ 360.400  Millions$ 54.936  Millions
Abbvie Inc   6.53 $ 86,911.000  Millions$ 13,303.000  Millions
Intercept Pharmaceuticals inc   6.50 $ 436.900  Millions$ 67.185  Millions
Jaguar Health inc   6.47 $ 49.577  Millions$ 7.660  Millions
Lifecore Biomedical Inc   5.90 $ 201.946  Millions$ 34.207  Millions
Amicus Therapeutics inc   5.83 $ 597.946  Millions$ 102.573  Millions
Tg Therapeutics inc   5.83 $ 159.846  Millions$ 27.433  Millions
Collegium Pharmaceutical inc   5.72 $ 1,027.693  Millions$ 179.733  Millions
Panbela Therapeutics Inc   5.50 $ 13.940  Millions$ 2.535  Millions
Ultragenyx Pharmaceutical Inc   5.27 $ 1,162.923  Millions$ 220.481  Millions
Dar Bioscience Inc   5.11 $ 25.395  Millions$ 4.972  Millions
Ionis Pharmaceuticals Inc   4.93 $ 2,398.651  Millions$ 486.570  Millions
Abvc Biopharma Inc   4.82 $ 8.353  Millions$ 1.735  Millions
Pieris Pharmaceuticals Inc   4.32 $ 66.800  Millions$ 15.458  Millions
Teva Pharmaceutical Industries Limited  4.13 $ 35,595.000  Millions$ 8,612.000  Millions
Timber Pharmaceuticals Inc   3.79 $ 4.966  Millions$ 1.311  Millions
Evoke Pharma Inc   3.68 $ 7.822  Millions$ 2.126  Millions
Mersana Therapeutics inc   3.61 $ 231.901  Millions$ 64.294  Millions
Travere Therapeutics Inc   3.27 $ 619.091  Millions$ 189.140  Millions
Mallinckrodt Plc  3.23 $ 4,406.400  Millions$ 1,364.400  Millions
Veru Inc   3.20 $ 53.538  Millions$ 16.716  Millions
Sarepta Therapeutics Inc   3.20 $ 2,279.798  Millions$ 712.749  Millions
Spectrum Pharmaceuticals Inc   3.02 $ 80.870  Millions$ 26.805  Millions

Date modified: 2023-05-05T20:49:15+00:00



Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071